A
Adline Chem Lab
ADLINE Share Price
Healthcare11.28
BSE
as on 23 Apr 2026 at 00:00
Market Cap
₹7 Cr
PE Ratio
282.00
ROCE
-74.83%
ADLINE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
7
PE Ratio
282.00
PB Ratio
-4.09
Dividend Yield
-
ROE
8.85%
ROCE
-74.83%
Book Value (₹)
-2.76
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 29.61% | 29.61% | 29.61% | 29.61% | 25.85% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 60.15% | 60.13% | 60.16% | 60.16% | 63.92% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
ADLINE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524604
NSE Scrip Name
ADLINE
ISIN
INE276T01018



